BioInformant.com is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by the Wall Street Journal, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution
By BioInformant Worldwide, L.L.C. | Pharmaceuticals and Healthcare | Jul 2017 | Page 123
The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution Traditionally, one of the major issues with commercializing cell therapy products has been manufacturing....
Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
By BioInformant Worldwide, L.L.C. | Pharmaceuticals and Healthcare | Jul 2017 | Page 166
Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives Stem cell research has been in process for over five decades. Stem cells have a....
